Conecte-se

Bibliografias temáticas / Polyclonale / Livros

Siga este link para ver outros tipos de publicações sobre o tema: Polyclonale.

Livros sobre o tema "Polyclonale"

Autor: Grafiati

Publicado: 7 de dezembro de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 18 melhores livros para estudos sobre o assunto "Polyclonale".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os livros das mais diversas áreas científicas e compile uma bibliografia correta.

1

Gray, Lynn. Dynamic antibody industry, including polyclonals and monoclonals. Norwalk, CT: Business Communications Co., 2002.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Rotheim, Philip. The dynamic antibody industry, including polyclonals and monoclonals. Norwalk, CT: Business Communications Co., 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Schmandt, Rosemarie Elizabeth. Production of polyclonal antibodies to protein kinase C. Ottawa: National Library of Canada, 1990.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Croll, Andrew David. The regulation of polyclonal mitogen-stimulated human gamma- interferon production. [s.l.]: typescript, 1986.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Rotheim, Philip. The dynamic monoclonal and polyclonal antibody business: Products, applications, and markets. Norwalk, CT: Business Communications Co., 1989.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Farooq, Muhammad. Glycosylation of monoclonal and polyclonal human IgG: Influences of protein structure and physiological environments. Birmingham: University of Birmingham, 1997.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Farooq, Muhammad. Glycosylation of monoclonal and polyclonal human IgG: Influences of protein structure and physiological environments. Birmingham: University of Birmingham, 1998.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Likitdecharote, Banchorn. Detection of mycoplasma infections in swine by culture and immunological methods using polyclonal and monoclonal antibodies. Hannover: [s.n.], 1987.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Boucher, Guillaume. Kinetic studies of alternative substrates for existing polyclonal catalytic antibodies. 2002.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Infectious molecular clones encoding the HIV clade C envelope and neutralizing polyclonal antibodies. 2007.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Carlino, Joseph A. Pregnancy-associated growth factor (PAGF): A T-dependent polyclonal activator of human lymphocytes. 1986.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

Thong, Bruce Yow Chin. Preparation of a new, specific polyclonal antibody that recognizes the carbohyrate moiety of digoxin. 1985.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Li, Hong. Analysis of bovine herpesvirus 4 (DN 599) proteins with monoclonal antibodies and polyclonal immune serum. 1990.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

Nassar, Abdul-Rahman Hassan. Development, characterization and application of polyclonal antibodies against ovine adipocytes for body fat reduction by passive immunization. 1989.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Piszel, Jane Louise. Biochemical characterization and production of polyclonal antibodies against two differentiation dependent nonhistone chromatin proteins from myocordial cells. 1987.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Barber, Nicola Jane. Evaluation of the pH dependence of a polyclonal catalytic antibody preparation and generation of an analogous monoclonal catalytic antibody. 1997.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Baker, Carlye Ann. Production and characterization of polyclonal and monoclonal antibodies to three virus-induced proteins of papaya ringspot virus type W. 1989.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Korbet, Stephen M., Melvin M. Schwartz e Edmund J. Lewis. Fibrillary and immunotactoid glomerulopathy. Editado por Neil Turner. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0081.

Texto completo da fonte

Resumo:

Fibrillary or immunotactoid nephropathy is a rare deposition disease of unknown cause in which highly organized deposits containing immunoglobulin and complement are found in the glomerular basement membrane and mesangium. These deposits are not amyloid fibrils and do not stain with Congo red. They are usually polyclonal and are not associated with monoclonal paraproteins, or with cryoglobulins or systemic lupus, distinguishing them from other non-amyloid fibrillary glomerulopathies. There is debate about whether there is a useful distinction between distinct fibrillary and rarer immunotactoid variants, the rarer immunotactoid variety being associated with larger, more organized, microtubular fibrils and possibly more commonly associated with malignancy (usually lymphoproliferative). However, clinically the conditions are similar. Patients usually present with heavy proteinuria or nephrotic syndrome. Microscopic haematuria is common and many have reduced glomerular filtration rate at presentation. Fifty per cent reach end-stage renal failure in 3–5 years and there is no convincing evidence that any treatment is effective in altering this outcome. Other organs appear to be affected only rarely (lung, liver). The disease may recur post-transplant but not always and usually more slowly, so does not preclude transplantation.

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!